Marta Zalacaín

1.4k citations
20 papers · 714 indexed · h-index 15
Topics
Sarcoma Diagnosis and Treatment (6 papers)Virus-based gene therapy research (5 papers)RNA Interference and Gene Delivery (4 papers)

In The Last Decade

Marta Zalacaín

20 papers receiving 705 citations

Peers

Marta Zalacaín
Comparison fields: 5 of 82
  • Molecular Biology 325
  • Oncology 229
  • Cancer Research 153
  • Pulmonary and Respiratory Medicine 134
  • Immunology 86
Replace Sioned Owen with:
Sioned Owen United Kingdom
Xiaoli Yang China
Miaoqing Zhao China
Christine R. Keenan Australia
Sandra O’Reilly United States
Akemi Sato Japan
Nandini Acharya United States
Huihui Wang China
Zhengming Wang China
Aihua Sun China
Marta Zalacaín relative to Sioned Owen United Kingdom Sioned Owen's profile →
Citations per field
00.5×1.5×1.9×
Sioned Owen · 1×
Citations per year

Countries citing papers authored by Marta Zalacaín

Since Specialization
Citations

This map shows the geographic impact of Marta Zalacaín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Zalacaín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Zalacaín more than expected).

Fields of papers citing papers by Marta Zalacaín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Zalacaín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Zalacaín. The network helps show where Marta Zalacaín may publish in the future.

Co-authorship network of co-authors of Marta Zalacaín

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Zalacaín. A scholar is included among the top collaborators of Marta Zalacaín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Zalacaín. Marta Zalacaín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 8
2 6
3 10
4 39
5 42
6 64
7 20
8 12
9 24
10 18
11 68
12 1
13 99
14 31
15 67
16 32
17 58
18 31
19 56
20 28

About Marta Zalacaín

Marta Zalacaín is a scholar working on Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 714 indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (6 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (4 papers). The work is most often cited by research in Cancer Research (153 citations), Oncology (229 citations) and Sensory Systems (26 citations). Marta Zalacaín has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Ana Patiño‐García, Luis Sierrasesúmaga, Mikel San-Julián, Antonio Pérez‐Martínez, Leticia T. Moreno, Guillermo Pita, Daniela Caronia, Lucía Marrodán, Javier Benı́tez and Anna González‐Neira. Their work appears in journals such as PLoS ONE, Cancer Research and Oncogene.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026